AB Bernstein
Wen Jiang, PhD, is a Senior Research Associate at AB Bernstein since August 2022, with prior experience as a Research Assistant at The Johns Hopkins University from August 2016 to August 2022. At Johns Hopkins, Wen conducted extensive research on the biological effects of alpha particle radiation on prostate cancer cells and contributed to biodistribution studies of Radium-223 in mouse models. Wen also served as a Teaching Assistant for systems biology and cell engineering courses and gained experience as a Research Intern at Sands Capital, focusing on biotech and medtech investments. Additionally, Wen contributed as a Pro Bono Consultant with the Johns Hopkins Graduate Consulting Club, evaluating oncological cell therapy candidates. Prior research experience includes roles at the State Key Laboratory of Bioelectronics and Jiangsu Key Laboratory of Biomaterials and Devices. Wen holds a PhD in Biomedical Engineering from The Johns Hopkins University School of Medicine and a Bachelor's degree in Biomedical Engineering from Southeast University.
This person is not in the org chart
AB Bernstein
Bernstein is widely recognized as Wall Street's premier sell-side research and brokerage firm, with a global equity trading platform that spans the U.S., Europe, and Asia. Our firm was founded in the U.S. in 1967 and in the U.K. in 1999. Our research and trading capabilities are sought out by leading investment managers around the world, and we are annually ranked at the top of our industry by acknowledged arbiters. In independent surveys of major institutional clients, Bernstein's research is ranked #1 for overall quality, industry knowledge, most trusted, best detailed financial analysis, major company studies, most useful valuation frameworks and best original research. In Institutional Investor’s latest annual client survey, the leading survey by which research analysts in our industry are evaluated, over 90% of our U.S. analysts and the majority of our European Analysts were recognized as among the best in their respective fields – more than any other firm in our industry. We began operations in Hong Kong in 2010, and now cover a range of sectors across Asia. Our European research team is also home to Extel's #1-ranked analyst across Europe. In April 2019 we acquired Autonomous Research, a highly regarded global financial services independent research firm. The combination of Bernstein and Autonomous solidifies our standing as the largest global independent research firm. Research has always been Bernstein's calling card. The brand is defined by our renowned Blackbooks, known for their unbiased, in-depth company and industry forecasts. We have a community of Research Analysts who are acknowledged thought leaders that typically have many years of experience in the industries they cover. Our reputation is for the very highest caliber of independent and disciplined investment and industry analysis. We are a wholly-owned subsidiary of our buy-side parent, AB.